Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Oropharyngeal candidiasis Age: Adult |
Dose: Capsule – 100 mg Frequency: once daily Duration: 15 days |
|
Indication: Vulvovaginal candidiasis Age: Adult |
Dose: Capsule – 200 mg Frequency: twice daily Duration: 1 day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child Condition: Conventional strength dosing |
Dose: Oral – 5 mg/kg Frequency: once daily Note: maximum per dose 200 mg |
|
Age: Child Condition: Invasive or disseminated infection (Conventional strength) |
Dose: Oral – 5 mg/kg Frequency: twice daily Note: maximum per dose 200 mg |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Capsules or Solution or Tablets – Dosage not specified Note: Limited data are available on use of oral itraconazole in patients with renal impairment; exercise caution when administering in this patient population |
Administration
- Take with food
- Take immediately after meals
Side Effect
- Rash (9%)
- Vomiting (5%)
- Edema (4%)
- Headache (4%)
- Abnormal liver function test results (3%)
- Diarrhea (3%)
- Fever (3%)
- Hypertension (3%)
- Pruritus (3%)
- Fatigue (2-3%)
- Abdominal pain (2%)
- Dizziness (2%)
- Hypertriglyceridemia (2%)
- Hypokalemia (2%)
- Albuminuria (1%)
- Anorexia (1%)
- Decreased libido (1%)
- Hepatitis (1%)
- Liver failure
- heart failure
- pulmonary oedema
- CV disease
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Oral Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), Digoxin, Cilostazol, Alprazolam, Midazolam (IV), Repaglinide, Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone)
|
May increase plasma concentrations
|
|
HIV Protease Inhibitors (Ritonavir, Atazanavir, Lopinavir, Nelfinavir, Saquinavir, Indinavir), Erythromycin, Clarithromycin
|
May increase plasma concentration
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hepatic disease
|
Risk of liver toxicity
|
|
Severe kidney disease (CrCl <30 mL/min)
|
Can accumulate to toxic levels
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C, away from light & in a dry place. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.